Regulation - North America

Filter

Current filters:

North America

Popular Filters

3190 to 3214 of 3305 results

Changing of the Guard begins in biotech sector

08-06-2011

The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Battle for share of US $8.5 billion in vitro diagnostic market

08-06-2011

The US in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing,…

Abbott LaboratoriesMarkets & MarketingNorth AmericaPharmaceuticalRoche

Russia should boost innovation to drive economic growth, says OECD

07-06-2011

Russia should increase protection of intellectual property, strengthen competition and invest more in…

EuropePatentsPharmaceuticalRegulationResearch

FDA accepts ciclesonide NDA from Nycomed partner Sunovion

07-06-2011

Swiss drugmaker Nycomed, the subject of a $13.7 billion takeover bid from Japan’s Takeda (TYO:4502;…

Ciclesonide Inhalation AerosolNorth AmericaNycomedPharmaceuticalRegulationRespiratory and PulmonarySunovion

Blow for Orexigen as regulatory demands see firm put obesity drug Contrave on hold

06-06-2011

Shares of US biotech firm Orexigen Therapeutics (Nasdaq: OREX) plunged 33% to $2.13 by afternoon trading…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulation

Johnson & Johnson faces $327 million penalty over Risperdal marketing

06-06-2011

Civil penalties amounting to just over $327 million have been announced in the case of State of South…

Johnson & JohnsonLegalNeurologicalNorth AmericaOrtho-McNeil-JanssenPharmaceuticalRisperdal

Good news for RVO suffers as EU approves Novartis’ Lucentis and NICE backs Allergan’s Ozurdex

06-06-2011

The European Commission has granted Novartis a new indication for Swiss drug major Novartis’ (NOVN:…

AllerganEuropeLucentisNovartisOphthalmicsOzurdexPharmaceuticalRegulation

US Biotech posts small gain in May, says Burrill

06-06-2011

It was a quiet month for US biotech with the Burrill Biotech Select Index recording a small 2.8% gain…

BiotechnologyFinancialNorth America

UK Pharma group ABPI has qualms about GMC proposal

06-06-2011

Responding to the UK General Medical Council (GMC) consultation on “Good practice in prescribing…

EuropePharmaceuticalRegulation

US FDA says use of ARBs for hypertension does not increase risk of cancer

03-06-2011

The US Food and Drug Administration stated yesterday that a group of drugs used to control high blood…

Cardio-vascularNorth AmericaPharmaceuticalRegulation

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue

03-06-2011

Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

CROMA and B&L’s eye drug Yellox approved by the European Commission

03-06-2011

Austria-based CROMA Pharma GmbH, a private global specialty pharmaceutical and surgical company, and…

Bausch & LombCROMA PharmaEuropeOphthalmicsPharmaceuticalRegulationYellox

Pfizer files for EU approval of axitinib in advanced kidney cancer

02-06-2011

The European Medicines Agency (EMA) has accepted US drugs behemoth Pfizer’s (NYSE: PFE) filing for…

axitinibEuropeOncologyPfizerPharmaceuticalRegulation

Health Canada OKs AstraZeneca’s Brilinta and new use for Merck’s Gardasil

02-06-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that Health Canada has approved Brilinta (ticagrelor…

AstraZenecaBrilintaCardio-vascularGardasilMerck & CoNorth AmericaOncologyPharmaceuticalRegulation

European Medicines Agency and HMA propose measures on dossier transparency

02-06-2011

A guidance document on the identification of commercially confidential information and protection of…

EuropePharmaceuticalRegulationResearch

Tianyin granted production license for diabetes drug Gliclazide by China's SFDA

02-06-2011

Tianyin Pharmaceutical (NYSE Amex: TPI), a China-based pharmaceutical company that specializes in patented…

Asia-PacificDiabetesGliclazidePharmaceuticalRegulationTianyin Pharma

Progress Report 2011: Health care renewal in Canada

02-06-2011

A new report on Canada's health care performance, released this week by the Health Council of Canada,…

HealthcareNorth AmericaPharmaceutical

European Commission to lift suspension of Octapharma MA for Octagam

01-06-2011

The European Commission has adopted the European Medicines Agency’s recommendation 2011 to lift…

EuropeOctagamOctapharmaPharmaceuticalRare diseasesRegulation

CBO Director reviews potential effects of a ban on DTC advertising of new Rx drugs in USA

01-06-2011

Direct-to-consumer (DTC) advertising of prescription drugs in the USA has elicited various concerns,…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

Changing the Indian culture in reporting adverse drug reactions

01-06-2011

Adverse drug reactions (ADRs) are the sixth global leading cause of death among hospitalized patients…

Asia-PacificBoehringer IngelheimPharmaceuticalRegulationResearch

Recommendations for European Medicines Agency communication on medicines; 40 years of PIC/S

01-06-2011

A report written by an independent expert has highlighted a number of recommendations to help improve…

EuropePharmaceuticalRegulation

MAP Pharma files NDA with US regulator for Levadex in migraine

31-05-2011

MAP Pharmaceuticals (Nasdaq: MAPP) has submitted a New Drug Application to the US Food and Drug Administration…

LevadexMAP PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalRegulation

3190 to 3214 of 3305 results

Back to top